Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;13(3):280-285.
doi: 10.5114/jcb.2021.106117. Epub 2021 May 13.

Reproducibility of vaginal immobilization balloons in situ overnight for cervical cancer brachytherapy

Affiliations

Reproducibility of vaginal immobilization balloons in situ overnight for cervical cancer brachytherapy

Uma D Goyal et al. J Contemp Brachytherapy. 2021 Jun.

Abstract

Purpose: The use of vaginal immobilization balloons placed into the vagina for immobilization of tandem and ovoid (T+O) applicator during high-dose-rate (HDR) brachytherapy delivery has been used at our institution, and seems to have improved our patient comfort, decreased procedure time, and minimized applicator misplacement. We aimed to show that these balloons, while originally marketed for single-day use, are safe and maintain applicator positioning/dosimetry when left in situ overnight for treatment delivery on sequential days.

Material and methods: Forty-two paired computed tomography (CT) scans from thirteen patients who underwent T+O HDR treatments on sequential days with vaginal immobilization balloons in situ overnight were retrospectively compared to calculate mean change of balloon volumes and balloon/T+O distance to bony landmarks. Dosimetric planning was retroactively performed on day 2 using CT scan of each pair, and the change in estimated radiation delivery to the bladder and rectum was compared.

Results: No statistically significant overnight changes were found in balloon volumes or anterior balloon positioning. The posterior balloon shifted -0.29 ±0.46 cm (p = 0.03) to the anterior public symphysis and 0.32 ±0.50 cm (p = 0.01) to the right femoral head. The tandem shifted 0.37 ±0.39 cm (p = 0.002) to the pubic symphysis. There was no significant difference found in radiation delivered to the bladder or rectum between the paired scans.

Conclusions: This study showed minimal change in balloon volumes, balloons/T+O positioning, or in radiation dose to bladder and rectum when the applicator remained overnight. These findings support that inflatable vaginal immobilization balloons remaining in situ overnight for additional HDR T+O treatments on sequential days, is safe and provides stable dosimetry.

Keywords: balloons; brachytherapy; overnight; ovoid; tandem.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflict of interest.

Figures

Fig. 1
Fig. 1
Volume of balloons overnight. A box-and-whisker plot comparison of the volumes of anterior and posterior balloons before (sim 1) and after (sim 2) overnight stay at the hospital, with balloons and T+O applicator remaining in situ
Fig. 2
Fig. 2
Distances between bony landmarks and balloons. A box-and-whisker plot comparison of distances between bony landmarks and anterior balloon, posterior balloon, and tandem with overnight change in distances between balloons and bone (femur indicates femoral head), with balloons and T+O applicator in situ
Fig. 3
Fig. 3
Organs at risk and dose. A box-and-whisker plot comparison of radiation dose delivered to bladder and rectum before (sim 1) and after (sim 2) overnight stay at the hospital, with balloons and T+O applicator remaining in situ

References

    1. Arbyn M, Weiderpass E, Bruni Let al. . Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health 2020; 8: e191-203. - PMC - PubMed
    1. Guo F, Cofie LE, Berenson AB. Cervical cancer Incidence in young U.S. females after human papillomavirus vaccine introduction. Am J Prev Med 2018; 55: 197-204. - PMC - PubMed
    1. Practice Bulletin No. 168: Cervical Cancer Screening and Prevention. Obstet Gynecol 2016; 128: e111-130. - PubMed
    1. Cho O, Chun M. Management for locally advanced cervical cancer: new trends and controversial issues. Radiat Oncol J 2018; 36: 254-264. - PMC - PubMed
    1. Gursel SB, Serarsian A, Meydan ADet al. . A comparison of tandem ring and tandem ovoid treatment as a curative brachytherapy component for cervical cancer. J Contemp Brachytherapy 2020; 12: 111-117. - PMC - PubMed